Selenium – containing mesoporous bioactive glass particles: Physicochemical and drug delivery properties
Source abstract
Abstract
Abstract Selenium (Se) incorporated mesoporous bioactive glasses (MBG) have been prepared using the traditional sol–gel method. The Se/MBG particles retain typical characteristics of mesoporous structures ( S BET =230–250 m 2 /g and D P =4.0–4.1 nm) and excellent hydroxyapatite formation ability when soaked in simulated body fluids for 3 days. To investigate their delivery properties further, doxorubicin (DOX) was selected as a model drug. The results indicate that the Se/MBG particles exhibit sustained DOX delivery, and controlled release mechanism by Fickian diffusion according the Higuchi model. Based on a favorable in vitro bioactive response and controllable DOX delivery, this material is a promising candidate for application in malignant bone tumor therapy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Selenium in Biological Systems · Laser-Ablation Synthesis of Nanoparticles
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Three-dimensional printing of strontium-containing mesoporous bioactive glass scaffolds for bone regeneration10.1016/j.actbio.2014.01.001 ↗
2. The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly (DL-lactide-co-glycolide) films10.1016/j.biomaterials.2009.01.029 ↗
3. Multifunctional mesoporous bioactive glasses for effective delivery of therapeutic ions and drug/growth factors10.1016/j.jconrel.2014.04.026 ↗
4. Multifunctional magnetic mesoporous bioactive glass scaffolds with a hierarchical pore structure10.1016/j.actbio.2011.06.028 ↗
5. Redox-responsive nanoreservoirs: the effect of different types of mesoporous silica on the controlled release of doxorubicin in solution and in vitro10.1016/j.micromeso.2014.12.026 ↗
6. Prediction of kinetics of doxorubicin release from sulfopropyl dextran ion-exchange microspheres using artificial neural networks10.1016/j.ejps.2004.12.005 ↗
7. Glycopolymer micelles with reducible ionic cores for hepatocytes-targeting delivery of DOX10.1016/j.ijpharm.2012.12.001 ↗
8. Tumor targeted quantum dotmucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer10.1016/j.jconrel.2011.02.015 ↗
9. Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe3O4 nanoparticle cores and a PEG-functionalized porous silica shell10.1039/c0cc02577a ↗
10. Transferrin as a drug carrier: cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells10.1016/j.tiv.2013.09.013 ↗
11. Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach10.1016/j.jconrel.2012.06.028 ↗
12. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting10.1016/j.ijpharm.2011.06.010 ↗
13. Synthesis of high surface area mesoporous bioactive glass nanospheres10.1016/j.matlet.2010.04.053 ↗
14. Functional mesoporous bioactive glass nanospheres: synthesis, high loading efficiency, controllable delivery of doxorubicin and inhibitory effect on bone cancer cells10.1039/c3tb20275e ↗
15. Corrosion protection of mesoporous bioactive glass coating on biodegradable magnesium10.1016/j.apsusc.2014.02.147 ↗
16. Mesoporous bioactive glasses for controlled drug release10.1016/j.micromeso.2007.04.041 ↗
17. Bioactive inorganic-materials/alginate composite microspheres with controllable drug-delivery ability10.1002/jbm.b.31621 ↗
18. Strontium-containing mesoporous bioactive glass scaffolds with improved osteogenic/cementogenic differentiation of periodontal ligament cells for periodontal tissue engineering10.1016/j.actbio.2012.06.023 ↗
19. Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity10.1016/j.biomaterials.2012.09.066 ↗
20. One-pot synthesis of magnetic and mesoporous bioactive glass composites and their sustained drug release property10.1016/j.actamat.2008.03.013 ↗
21. Evaluation of zinc and magnesium doped 45S5 mesoporous bioactive glass system for the growth of hydroxyl apatite layer10.1016/j.jnoncrysol.2014.09.050 ↗
22. Novel selenium-doped hydroxyapatite coatings for biomedical applications10.1002/jbm.a.34387 ↗
23. Titanium surfaces with adherent selenium nanoclusters as a novel anticancer orthopedic material
24. Preparation and characterization of selenite substituted hydroxyapatite10.1016/j.msec.2012.09.011 ↗
25. How useful is SBF in predicting in vivo bone bioactivity10.1016/j.biomaterials.2006.01.017 ↗
26. Probe spectrum measurements of Eu3+ ions as a relevant tool for monitoring in vitro hydroxyapatite formation in a new borate biomaterial10.1039/C4TB00871E ↗
27. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system10.1016/j.jconrel.2005.11.002 ↗
28. Curcumin release from cerium, gallium and zinc containing mesoporous bioactive glasses10.1016/j.micromeso.2013.06.014 ↗
29. Mesoporous bioactive scaffolds prepared with cerium-, gallium- and zinc-containing glasses10.1016/j.actbio.2012.09.024 ↗
30. Ordered mesoporous bioactive glasses for bone tissue regeneration10.1021/cm060488o ↗
31. Maintaining the pluripotency of mouse embryonic stem cells on gold nanoparticle layers with nanoscale but not microscale surface roughness10.1039/c4nr01540a ↗
32. Mesoporous materials for drug delivery10.1002/anie.200604488 ↗
33. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds10.1016/j.micromeso.2008.08.046 ↗
34. The effect of zirconium incorporation on the physiochemical and biological properties of mesoporous bioactive glasses scaffolds10.1016/j.micromeso.2011.03.007 ↗
35. Microfluidics: a focus on improved cancer targeted drug delivery systems10.1016/j.jconrel.2013.07.028 ↗
36. Investigation of emulsified, acid and acid-alkali catalyzed mesoporous bioactive glass microspheres for bone regeneration and drug delivery10.1016/j.msec.2013.06.022 ↗
37. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices10.1002/jps.2600521210 ↗